Nasdaq Stockholm AB: The observation status for Karessa Pharma Holding AB (publ) is updated (56/20)

Today, February 7, 2020, Karessa applied for delisting of its shares from Nasdaq First North Growth Market. The rules of Nasdaq First North Growth Market state that an issuer may be given observation …
(Orginal – Story lesen…)

This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny
700